✦ LIBER ✦

Phase 1 study of efatutazone, a novel oral peroxisome proliferator-activated receptor gamma agonist, in combination with FOLFIRI as second-line therapy in patients with metastatic colorectal cancer

✍ Scribed by Komatsu, Yoshito; Yoshino, Takayuki; Yamazaki, Kentaro; Yuki, Satoshi; Machida, Nozomu; Sasaki, Takahide; Hyodo, Ichinosuke; Yachi, Yutaka; Onuma, Hiroshi; Ohtsu, Atsushi

Book ID: 121591887
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 279 KB
Volume: 32
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-013-0056-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

639 POSTER Phase I/II study of PTK/ZK, a

639 POSTER Phase I/II study of PTK/ZK, a novel, oral angiogenesis inhibitor in combination with FOLFIRI as first-line treatment for patients with metastatic colorectal cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 247 KB

14LBA Randomized phase 3 study of panitu

14LBA Randomized phase 3 study of panitumumab with FOLFIRI vs FOLFIRI alone as second-line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC)

✍ M. Peeters; T. Price; Y. Hotko; A. Cervantes; M. Ducreux; T. André; E. Chan; F. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

An Open-label, Single-arm, Phase 2 Trial

An Open-label, Single-arm, Phase 2 Trial of Panitumumab Plus FOLFIRI as Second-line Therapy in Patients with Metastatic Colorectal Cancer

✍ Allen L. Cohn; Grace C. Shumaker; Pankaj Khandelwal; David A. Smith; Marcus A. N 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 429 KB

‘A phase II study of oral uracil/ftorafu

‘A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer’

✍ Bennouna, J; Perrier, H; Paillot, B; Priou, F; Jacob, J H; Hebbar, M; Bordenave, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 111 KB

9059 POSTER Phase 1b Study of Oral PPAR-

9059 POSTER Phase 1b Study of Oral PPAR-gamma Agonist Efatutazone (CS-7017) in Combination With Carboplatin and Paclitaxel in Chemotherapy-Naive Korean Patients With Metastatic or Unresectable Locally Advanced Non-Small Cell Lung Cancer

✍ Park, K.; Ahn, M.J.; Ahn, J.S.; Lee, J.; Sun, J.M.; Yi, J.H.; Cho, S.H.; Lee, J. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

3061 POSTER Phase I/II study of novel or

3061 POSTER Phase I/II study of novel oral fluoropyrimidine S-1 in combination with oxaliplatin (SOX) as first-line chemotherapy for metastatic colorectal cancer (mCRC)

✍ M. Tahara; Y. Yamada; A. Ohtsu; K. Shirao; Y. Shimada; Y. Sasaki; W. Yamamoto; T 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB